KDM6A and hepatocellular carcinoma: Next, to investigate the relationship between KDM6A expression and clinical outcomes, we first divided all HCC samples in the TCGA_LIHC cohort into a high KDM6A expression group and a low KDM6A expression group based on the median mRNA level of KDM6A.